Aperiomics

Aperiomics is a biotech company that combines the latest advancements in science, technology, and medicine to change the way healthcare providers identify causes of infection.

Aperiomics is the only company of its kind and scope in the world.

Aperiomics was founded in 2013 by Crystal Icenhour and Yuan (Alvin) Chen. The company is headquartered in Sterling, Virginia.

Aperiomics is revolutionizing the way that medical professionals around the world identify infections.

Aperiomics identifies every known bacteria, virus, fungus, and parasite through Deep Shotgun Metagenomic Sequencing, using our world renown database containing over 37,000 microbes.

 

Aperiomics helps doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome.

 

Aperiomics is backed by VentureSouth, Pipeline Angels, Atlanta Technology Angels, The Launch Place, Central Texas Angel Network and others. The company raised an additional $1.2M in Series A financing on Dec 07, 2020, brining its Series A total to $3M. This brings Aperiomics' total funding to $3.5M to date.

 

 

  • Year founded: 2013
  • Funding Info: $3.5M over 3 Rounds (Latest Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Sterling
  • State: Virginia
  • Country: United States
Related businesses